SCHEMBL5377909

SCHEMBL5377909

CCCCc1cc(SOSc2ccc(N)c(CCCC)c2)ccc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
SKP2 Q13309 1/20 0.41
TYR P14679 2/20 0.39
TLR8 Q9NR97 2/20 0.36
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX5 P09917 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5379533 0.95 MAPT (0.41) MAPTALDH1A1POLBSKP2TYR
SCHEMBL5381223 0.94 ALOX5 (0.41) MAPTALDH1A1POLBSKP2TYR
SCHEMBL434003 0.90 ALDH1A1 (0.44) MAPTALDH1A1POLBSKP2MEN1
SCHEMBL5377030 0.84 MAPT (0.45) MAPTALDH1A1POLBSKP2TYR
SCHEMBL5381291 0.82 ALDH1A1 (0.59) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL5385973 0.81 TYR (0.38) MAPTALDH1A1SKP2TYRTLR8
SCHEMBL5379527 0.79 MAPT (0.44) MAPTALDH1A1POLBSKP2TYR
SCHEMBL31457283 0.79 CYP3A4 (0.45) MAPTALDH1A1POLBSKP2TYR
SCHEMBL19175490 0.78 MAPT (0.42) MAPTALDH1A1POLBSKP2TYR
SCHEMBL5381219 0.78 MAPT (0.42) MAPTALDH1A1POLBSKP2TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202359-B2 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2007-04-10 US disclosed
CN-1234706-C Nitrogen-oxygen heterocyclic compound and preparation method thereof CHANGCHUN ARTIFICIAL RESIN FAC (CN) 2006-01-04 CN disclosed
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2005-04-21 US disclosed
CN-1490318-A Nitrogen-oxygen heterocyclic compound and preparation method thereof 长春人造树脂厂股份有限公司 2004-04-21 CN disclosed
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 MAPT 2811/4885ALDH1A1 81/4885POLB 1238/4885
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 MAPT 2734/4885ALDH1A1 116/4885POLB 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.